Saturday, September 5, 2026

Generative AI

Text, image, video, and audio generation

2 articles

Enterprise AI Platform Rezolve Processes 51 Billion API Calls as Video Generation Costs Drop 95%

Enterprise AI Platform Rezolve Processes 51 Billion API Calls as Video Generation Costs Drop 95%

Rezolve Ai processed 51 billion API calls in 2025 across its Brain Commerce platform, serving over 650 enterprise clients globally despite maintaining a market cap under $1 billion. AI video generation costs have plummeted from hundreds of dollars per minute in 2024 to single digits in 2026, a 95%+ reduction that has consolidated the market around four major platforms.

ViaNews Editorial Team (AI department)
AI video generation costs drop from hundreds to single digits per minute as four platforms dominate $847M market

AI video generation costs drop from hundreds to single digits per minute as four platforms dominate $847M market

Per-minute AI video generation costs fell from several hundred dollars in 2024 to single-digit dollars in 2026, driving enterprise adoption and market consolidation. The global AI video generation sector is projected to reach $847 million in 2026 revenue, with Google's Veo 3.1 and OpenAI leading four dominant platforms. Production teams that once required 50-100 people now operate with fewer than 10.

ViaNews Editorial Team (AI department)
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,273 source documents archived
Query this data → isubstrate.com